Tomonil (1.5 mg Tablet)
Tablet containing tomonil — over-the-counter medicine
Quick Facts About Tomonil
Key Takeaways About Tomonil
- Over-the-counter: Tomonil does not require a prescription, but it is a medicine – not a supplement – and must be used responsibly
- Low-dose tablet: Each tablet contains only 1.5 mg of tomonil, so small dosing errors (for example taking several extra tablets) can meaningfully change the total dose
- Short-term use: OTC self-treatment is intended for short, self-limiting symptoms – if complaints last more than a few days, consult a healthcare professional
- Check for interactions: Tell your pharmacist about all prescription drugs, OTC products, and herbal remedies you already use before starting Tomonil
- Read the leaflet: The official package leaflet supplied with Tomonil is the primary source of binding information about indications, dosing, contraindications, and side effects
What Is Tomonil and What Is It Used For?
Tomonil is an over-the-counter medicine supplied as 1.5 mg oral tablets, containing the active substance tomonil. It is intended for short-term self-treatment of mild, self-limiting symptoms as described in the package leaflet. Because it is OTC, it can be purchased without a prescription, but it should still be used according to the directions on the label.
Tomonil belongs to the category of over-the-counter (OTC) medicines. In most regulatory systems, including those overseen by the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and the World Health Organization (WHO), OTC status is granted only to medicines that have demonstrated an acceptable safety profile in the general population, have a well-understood therapeutic effect, and can be used appropriately by consumers without individual medical supervision, provided that the package leaflet is followed carefully. The tablet formulation of Tomonil is designed for oral administration and is intended to be swallowed whole.
The active substance in each Tomonil tablet is tomonil, present at a strength of 1.5 mg. This relatively low per-tablet dose is typical for OTC products where the goal is to provide effective symptomatic relief while keeping the risk of adverse effects in healthy, non-vulnerable users to a minimum. The milligram strength chosen reflects a balance between efficacy, safety, and convenience; because the dose per tablet is small, small deviations from the recommended dose can still lead to meaningful changes in the total amount of active substance you take, especially if you already use other medicines containing similar active ingredients.
Tomonil is used for the short-term, symptomatic relief of mild, self-limiting complaints as stated in the official package leaflet. The term “self-limiting” refers to conditions that are generally expected to resolve on their own within a few days, with or without treatment. OTC medicines like Tomonil are typically indicated in such situations, where treatment aims to relieve discomfort rather than cure a disease. If your symptoms are severe, persistent (more than a few days), recurrent, or associated with warning signs such as high fever, sudden weight loss, severe pain, bleeding, or neurological symptoms, OTC self-treatment is not appropriate and you should consult a healthcare professional.
Tomonil is sold under the brand name Tomonil. In some countries, an OTC medicine with the same active substance may also be marketed under different brand names, or as a generic. The tablet identification markings, size, and colour of a specific package may vary between manufacturers and batches, so always verify the product name, strength, and expiry date on the blister and outer carton before use.
Although Tomonil is available without a prescription, it is still a medicine. Use it only for the indication described in the package leaflet, at the recommended dose, and for the recommended duration. If in doubt, ask your pharmacist – pharmacists are trained to provide evidence-based advice on OTC medicines and can help you decide whether Tomonil is suitable for your situation.
What Should You Know Before Taking Tomonil?
Before using Tomonil, read the package leaflet carefully, check the list of active and inactive ingredients against any known allergies, and review your other medicines for possible interactions. Consult a pharmacist or doctor before use if you are pregnant, breastfeeding, under 18 years of age, elderly, or living with a chronic medical condition.
Contraindications
Do not take Tomonil if you are allergic (hypersensitive) to the active substance tomonil or to any of the inactive ingredients (excipients) listed in section 6 of the package leaflet. An allergic reaction can manifest as skin rash, itching, swelling of the face, lips, tongue or throat, difficulty breathing, wheezing, or a sudden drop in blood pressure. Severe allergic reactions (anaphylaxis) are medical emergencies and require immediate attention.
Do not use Tomonil if the tamper-evident seal of the package has been broken, if the blister is damaged, if the tablet appearance differs from that described in the leaflet, or if the expiry date has passed. Tomonil is not intended for use in situations that fall outside the indication described in the leaflet. If you are uncertain whether the symptom you want to treat is appropriate for self-care with Tomonil, do not start treatment without first consulting a pharmacist or doctor.
If you have previously experienced a hypersensitivity reaction to any medicine that contains tomonil or to a chemically related substance, inform your pharmacist before buying Tomonil. Cross-reactivity between similar compounds is possible and a safer alternative may be recommended.
Warnings and Precautions
Talk to your pharmacist or doctor before taking Tomonil if any of the following apply to you:
- Chronic disease: If you live with a long-term condition such as cardiovascular disease, diabetes, asthma, epilepsy, a bleeding disorder, or a mental health condition, seek advice before adding any new medicine
- Liver impairment: Reduced liver function can affect the way tomonil is broken down by the body and may increase the risk of side effects
- Kidney impairment: Reduced kidney function may affect elimination of the active substance and its metabolites, and may warrant caution or dose adjustment
- Multiple medicines: If you are already taking several prescription or OTC medicines, the risk of drug interactions increases; ask your pharmacist to review your full medication list
- Recent surgery or hospitalisation: After surgery, hospitalisation, or a change in diagnosis, it is safer to check with your doctor before resuming OTC products
- Alcohol use: Regular or heavy alcohol use can alter how medicines are metabolised and may increase the risk of adverse effects
Use Tomonil for the shortest duration required to relieve your symptoms. If you have been using Tomonil for the maximum period recommended in the package leaflet without improvement, stop self-treatment and consult a healthcare professional. Chronic, uncontrolled symptoms may signal an underlying condition that requires a formal diagnosis and a more specific therapy than OTC self-care can provide.
Driving and operating machinery: some OTC medicines can cause drowsiness, dizziness, or blurred vision that may affect your ability to drive or operate heavy machinery safely. Until you know how Tomonil affects you personally, avoid activities that require full alertness. If you notice any of these symptoms, do not drive until they have fully resolved.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, or are planning to become pregnant, ask your doctor, midwife, or pharmacist for advice before taking Tomonil. As a general principle, no medicine – including over-the-counter products – should be used during pregnancy unless clearly necessary. Your healthcare provider will weigh the expected benefit of symptom relief against the potential risks to the developing fetus.
It is not known to what extent the active substance tomonil passes into breast milk. If you are breastfeeding or planning to breastfeed, discuss the use of Tomonil with your healthcare provider before starting. In many cases, non-pharmacological measures or alternative treatments with a better-characterised safety profile during lactation may be preferred. If treatment is considered necessary, your clinician will help you decide whether to temporarily interrupt breastfeeding or to choose an alternative medicine.
Women of childbearing potential who are sexually active without reliable contraception should discuss the use of Tomonil with their healthcare provider, particularly for longer courses of treatment. If you discover that you are pregnant while taking Tomonil, do not panic: stop the medicine and contact your doctor or midwife for advice. Many OTC medicines have been used by women before they knew they were pregnant without any negative outcome, but a personalised assessment is always the right approach.
Never self-treat during pregnancy without professional advice. Even OTC medicines can have implications for the developing baby that are not obvious from the product label. Ask your doctor, midwife, or pharmacist before using Tomonil.
How Does Tomonil Interact with Other Drugs?
Tomonil may interact with other medicines, including prescription drugs, other over-the-counter products, vitamins, and herbal supplements. Always tell your pharmacist what you already take before starting Tomonil. Particular caution is needed with medicines that act on the central nervous system, on blood clotting, or that share similar metabolic pathways.
Drug interactions occur when one medicine influences the way another medicine is absorbed, distributed, metabolised, or eliminated by the body (pharmacokinetic interactions), or when two medicines produce additive, synergistic, or opposing effects on the same physiological target (pharmacodynamic interactions). For OTC products like Tomonil, the most important clinical concern is that users may not always report their OTC use to their prescribing doctor or pharmacist, which means interactions can be missed. Keeping a single up-to-date list of everything you take – including OTC tablets, herbal teas, and dietary supplements – is the simplest way to prevent this.
Pharmacokinetic interactions involving Tomonil may occur if the active substance is metabolised by common hepatic enzymes (for example the cytochrome P450 family) that are also used to metabolise many other medicines. A medicine that inhibits these enzymes may raise the blood level of tomonil and increase the risk of side effects, while a medicine that induces the enzymes may reduce its effectiveness. Medicines that bind to the active substance in the gut, such as certain antacids or iron and calcium supplements, may reduce absorption if taken at the same time.
Pharmacodynamic interactions become important when Tomonil is combined with medicines that have overlapping effects. For example, combining an OTC product that causes drowsiness with a prescription sedative, a sleep aid, or alcohol can produce excessive sedation. Combining medicines that each have a small effect on blood clotting (such as an anticoagulant plus an OTC analgesic with antiplatelet effect) can raise bleeding risk more than either product alone.
The table below summarises the most common categories of interacting medicines for OTC tablets in general; it is not exhaustive and is provided for guidance only. The authoritative list of known interactions for Tomonil is found in the package leaflet; additional interactions may be recognised over time as post-marketing data accumulate.
Major Interactions
| Drug / Drug Class | Type of Interaction | Clinical Significance | Recommendation |
|---|---|---|---|
| CNS depressants (sedatives, sleep aids, opioids) | Pharmacodynamic | Additive drowsiness, impaired coordination | Avoid combining without medical advice |
| Anticoagulants (e.g., warfarin, DOACs) | Pharmacodynamic | Possible increased bleeding risk | Consult your prescriber before starting |
| CYP450 inhibitors (e.g., some antifungals, macrolide antibiotics) | Pharmacokinetic | May raise tomonil blood levels | Ask pharmacist; avoid prolonged combined use |
| CYP450 inducers (e.g., rifampicin, carbamazepine, St John’s Wort) | Pharmacokinetic | May reduce effectiveness of Tomonil | Discuss alternatives with your prescriber |
| Antacids, iron, calcium supplements | Absorption | May reduce gut absorption of Tomonil | Separate doses by at least 2 hours |
| Alcohol | Pharmacodynamic / metabolic | Increased drowsiness, stomach irritation, altered metabolism | Limit or avoid alcohol during treatment |
Minor Interactions and Everyday Products
Not all interactions are clinically significant. Some everyday foods, drinks, and herbal products can have mild effects on OTC medicines without causing obvious harm, yet they are still worth mentioning to your pharmacist. Grapefruit and grapefruit juice, for example, are well known to inhibit certain intestinal enzymes and can raise the blood levels of several medicines. Green tea, caffeine, and herbal teas containing unknown extracts may also exert mild interactions.
Dietary supplements deserve particular attention. Supplements such as high-dose vitamin E, fish oil, ginkgo biloba, and garlic can influence platelet function and are potentially relevant for people already taking anticoagulants or antiplatelet drugs. Although Tomonil is not specifically an antithrombotic medicine, the general principle of assessing cumulative risk applies: the more bioactive substances you take at once, the higher the theoretical risk of an unexpected effect.
If you use recreational substances, it is particularly important to be honest with your healthcare provider. Non-prescribed psychoactive substances may interact with OTC medicines in unpredictable ways. Confidential conversations with your pharmacist or doctor are covered by professional secrecy and enable a safer assessment of your individual risk.
Alcohol can worsen common side effects of OTC medicines, particularly drowsiness, dizziness, and stomach upset. Alcohol can also affect the way medicines are metabolised by the liver. It is generally safest to limit or avoid alcohol while taking Tomonil; ask your pharmacist for guidance if you have any specific concerns.
What Is the Correct Dosage of Tomonil?
Each Tomonil tablet contains 1.5 mg of the active substance. Follow the dosing instructions on the package leaflet exactly. Do not exceed the maximum daily dose or the maximum duration of use stated on the packaging. Seek advice from a pharmacist if you are unsure about the correct dose for your situation.
The correct dosage of Tomonil depends on several factors, including the severity of your symptoms, your age, your body weight, your general health, the presence of any liver or kidney impairment, and which other medicines you are currently taking. Because Tomonil is available without a prescription, the package leaflet provides a simple and safe dosing scheme designed for the general adult population. Stepping outside this scheme (for example by taking higher or more frequent doses) increases the risk of adverse effects without a proportional increase in benefit.
Adults
Standard Adult Dosage
Adults should take Tomonil as described in the package leaflet. The typical dose is one 1.5 mg tablet, taken orally with a glass of water, at intervals specified on the label. Do not exceed the maximum recommended daily dose, and do not continue treatment beyond the maximum recommended duration, which is usually only a few days for OTC indications.
Swallow the tablet whole. Do not crush, split, or chew the tablet unless the package leaflet specifically allows it. If you have difficulty swallowing tablets, ask your pharmacist whether an alternative formulation is available. Taking the tablet with food or water does not change the active ingredient, but a full glass of water helps ensure the tablet reaches the stomach and dissolves properly.
Children and Adolescents
Paediatric Use
Tomonil 1.5 mg tablets are generally intended for adult self-care. The safety and efficacy of Tomonil in children and adolescents under 18 years of age have not been specifically established in all clinical settings. Do not give Tomonil to a child without consulting a doctor or pharmacist first. Children often require different doses based on body weight and may be more sensitive to both the desired effects and the side effects of medicines.
If a healthcare professional advises you to give Tomonil to a child, follow the dosing instructions precisely, use a weighing scale rather than estimating body weight, and never use adult doses for children. Keep Tomonil out of reach and sight of children at all times.
Elderly Patients
Geriatric Dosage Considerations
Older adults (typically 65 years and over) may be more sensitive to the effects of medicines due to age-related changes in organ function, in particular reduced kidney and liver function, and because they often take several medicines at once. Elderly patients are also more vulnerable to falls when a medicine causes drowsiness or dizziness.
If you are 65 years or older, consider starting with the lower end of the recommended dose range stated in the package leaflet, and monitor carefully for side effects. If you are unsure, ask a pharmacist or doctor to review whether Tomonil is suitable alongside your existing medicines.
Missed Dose
If you take Tomonil on a regular schedule and you miss a dose, take it as soon as you remember. However, if it is nearly time for the next scheduled dose, skip the missed dose and continue with your normal dosing schedule. Do not take a double dose to make up for the one you missed; doubling the dose does not improve symptom relief and only increases the risk of side effects.
Many people use OTC medicines like Tomonil only when symptoms occur, rather than on a fixed schedule. In that situation there is no “missed dose” in the strict sense: simply take the tablet when you actually need it, within the limits set out in the package leaflet.
Overdose
If you accidentally take more Tomonil tablets than recommended, or if someone else (especially a child) swallows your tablets, contact your local poison control centre, call your national emergency number, or go immediately to the nearest emergency department. Take the Tomonil package with you so that healthcare staff can see exactly which product, which strength, and how many tablets were involved. Do not wait for symptoms to develop before seeking help – early assessment is the safest strategy.
Symptoms of overdose vary depending on the amount ingested and the individual. Possible signs include nausea, vomiting, dizziness, drowsiness, headache, fast or irregular heartbeat, confusion, or other unusual symptoms. Some overdose effects may not appear immediately, which is another reason to seek medical evaluation even if the person appears well.
| Patient Group | Typical Approach | Notes |
|---|---|---|
| Adults (18–64 years) | 1.5 mg tablet(s) per package leaflet | Use the lowest effective dose for the shortest necessary time |
| Elderly (≥65 years) | Start at the lower end of recommended dose range | Monitor for dizziness, drowsiness, falls; review other medicines |
| Children (<18 years) | Not routinely recommended | Only under guidance from a doctor or pharmacist |
| Renal impairment | Use with caution | Ask pharmacist; dose may need adjustment |
| Hepatic impairment | Use with caution | Altered metabolism possible; consult a healthcare professional |
| Pregnancy / breastfeeding | Use only if clearly necessary | Always consult a doctor, midwife, or pharmacist first |
What Are the Side Effects of Tomonil?
Like all medicines, Tomonil can cause side effects, although not everyone who takes it experiences them. Most side effects are mild, short-lived, and resolve on their own. Stop taking Tomonil and seek medical advice if you develop severe symptoms, signs of an allergic reaction, or any effect that concerns you.
Side effects are adverse reactions that may occur when a medicine is used as recommended. They are usually classified by frequency using a scheme standardised by international pharmacovigilance bodies: very common (more than 1 in 10 people), common (1 in 10 to 1 in 100), uncommon (1 in 100 to 1 in 1,000), rare (1 in 1,000 to 1 in 10,000), and very rare (fewer than 1 in 10,000). For many OTC products, very common side effects are uncommon in absolute terms, because the medicine has been selected for its favourable safety profile.
It is important to distinguish between predictable pharmacological side effects, which are often dose-related and may improve as the body adjusts, and allergic reactions, which can occur even at the first dose and are triggered by the immune system. Signs of a serious allergic reaction (anaphylaxis) include difficulty breathing, swelling of the face, lips, tongue or throat, severe skin rash or hives, dizziness, fainting, or a rapid heartbeat. Anaphylaxis is a medical emergency. Stop taking Tomonil and call your local emergency number if any of these signs appear.
Many mild side effects – such as transient headache, nausea, or fatigue – can be managed simply by drinking enough water, eating small balanced meals, and resting. If a side effect persists, worsens, or affects your daily life, stop taking the medicine and ask a healthcare professional for advice. Even for OTC products, reporting suspected side effects to your national pharmacovigilance authority is encouraged; real-world data from these reports helps regulators and manufacturers detect new or rare safety signals and keep the information in the package leaflet up to date.
Very Common Side Effects
May affect more than 1 in 10 people
- No very common side effects are typically expected for Tomonil at the 1.5 mg tablet strength
- Refer to the package leaflet for the most recent information
Common Side Effects
May affect up to 1 in 10 people
- Headache
- Mild nausea
- Dizziness
- Fatigue or drowsiness
- Abdominal discomfort, bloating, or mild stomach pain
- Dry mouth
Uncommon Side Effects
May affect up to 1 in 100 people
- Mild skin rash or itching
- Diarrhoea or constipation
- Insomnia or disturbed sleep
- Changes in appetite
- Muscle or joint aches
- Palpitations or mildly fast heartbeat
Rare Side Effects
May affect up to 1 in 1,000 people
- Hypersensitivity or allergic reaction
- Elevated liver enzymes
- Changes in blood cell counts
- Mood changes, anxiety, low mood
- Visual disturbances
- Severe skin reactions (very rare)
Signs of a serious allergic reaction such as swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe skin rash with blistering or peeling; rapid heartbeat; fainting; severe abdominal pain; or black, tarry stools. These symptoms require emergency evaluation. Stop taking Tomonil immediately and call your local emergency number or go to the nearest emergency department.
You are encouraged to report any suspected side effect to your pharmacist, doctor, or directly to your national pharmacovigilance authority. Reporting helps regulatory bodies detect rare or previously unknown reactions and improve the safety information available for all users. For OTC medicines in particular, user-reported data are a vital source of post-marketing safety surveillance, because many users never see a doctor during a course of self-treatment.
How Should You Store Tomonil?
Store Tomonil at room temperature below 25°C (77°F) in the original packaging. Keep out of reach and sight of children. Do not use Tomonil after the expiry date printed on the packaging. Return unused tablets to your pharmacy for safe disposal.
Proper storage is essential to maintain the quality, stability, and safety of any medicine. Tomonil 1.5 mg tablets should be kept in a cool, dry place where the temperature does not exceed 25°C (77°F). Avoid storing the tablets in places where temperature and humidity fluctuate, such as bathrooms or the kitchen near a stove or dishwasher. High humidity can degrade the tablet coating and may affect the chemical stability of the active substance.
Keep Tomonil in its original packaging until you are ready to use it. The blister and outer carton are designed to protect the tablets from light and moisture, and to provide essential information such as batch number and expiry date. Do not transfer tablets to unlabelled containers, and do not combine different medicines in the same pill organiser without clear, individual labelling. If you use a weekly pill organiser, store the remaining tablets in their original blister in a dry location.
Always keep Tomonil and all other medicines out of reach and sight of children. Accidental ingestion of OTC tablets by young children is a common cause of poison-centre calls. Even medicines with a favourable adult safety profile can cause significant harm in small children at adult doses. Store medicines in a locked or high cabinet and never refer to tablets as “sweets” when speaking with children.
Do not use Tomonil after the expiry date stated on the carton and blister. The expiry date refers to the last day of the month shown. Using an expired medicine may reduce its effectiveness and, in some cases, generate degradation products that are not well characterised. Check the expiry date regularly, and discard any package that is past its date or that has been damaged, exposed to extreme conditions, or stored in unknown conditions.
Do not dispose of Tomonil via household waste or wastewater. Medicines in wastewater can contaminate drinking-water sources and natural ecosystems. Most pharmacies operate take-back schemes that safely collect and destroy unused medicines. Ask your local pharmacist for the correct procedure in your country; the small effort of taking unused tablets back to the pharmacy has a meaningful environmental impact.
What Does Tomonil Contain?
Each Tomonil tablet contains 1.5 mg of the active substance tomonil, together with pharmaceutical excipients that support the tablet’s structure, stability, and appearance. The exact list of excipients is provided in section 6 of the official package leaflet.
The active substance in each Tomonil tablet is tomonil 1.5 mg. This is the ingredient responsible for the pharmacological effect of the medicine. The strength has been determined through formulation development and clinical testing to provide a useful therapeutic effect while keeping the risk of side effects in healthy adult users to a minimum. In OTC products, this balance between efficacy and safety is the foundation of the decision to allow sale without a prescription.
In addition to the active ingredient, every tablet contains a number of inactive ingredients (excipients). Excipients serve several purposes: they provide the physical bulk of the tablet, help compress the powders into a tablet that does not fall apart during handling, control how the tablet breaks up in the stomach, reduce sticking to the tableting machinery, and – in the case of coated tablets – provide a smooth surface for identification markings. Common excipients in oral tablets include microcrystalline cellulose, lactose monohydrate, starch derivatives, croscarmellose sodium, magnesium stearate, and silica-based flow aids.
If you have known allergies or intolerances to pharmaceutical excipients – for example lactose intolerance or gluten sensitivity – check the excipient list in the package leaflet carefully before use, or ask your pharmacist. Many excipients are present in very small quantities and are unlikely to cause problems, but specific intolerances (such as hereditary fructose intolerance or galactose intolerance) may be relevant and must be respected. The complete list of excipients for your specific Tomonil package is printed in the patient information leaflet included in the carton.
Tomonil is sold under the brand name Tomonil. The appearance of the tablet (shape, colour, embossed markings) may vary slightly between different batches or packages depending on local regulatory requirements. The outer carton and blister foil always display the product name, strength, batch number, and expiry date. If your tablets do not match the description in the leaflet, do not take them; return the package to the pharmacy where you purchased it for verification.
Frequently Asked Questions About Tomonil
Tomonil is an over-the-counter medicine supplied as 1.5 mg tablets containing the active substance tomonil. It is used for the short-term, symptomatic relief of mild, self-limiting complaints as described in the package leaflet. Because Tomonil is sold without a prescription, it is intended for responsible self-care in adults. If your symptoms are severe, persistent, or accompanied by warning signs such as high fever, severe pain, or bleeding, self-treatment is not appropriate and you should consult a healthcare professional instead.
Swallow the 1.5 mg tablet whole with a glass of water. Follow the dosing instructions printed on the package leaflet or on the outer carton. Do not crush, split, or chew the tablet unless the leaflet says it is allowed. Take the medicine at the intervals specified, do not exceed the maximum daily dose, and do not continue treatment beyond the maximum duration recommended for self-care. If symptoms do not improve within a few days, stop Tomonil and consult a pharmacist or doctor.
If you take Tomonil on a regular schedule and miss a dose, take it as soon as you remember. However, if it is nearly time for the next scheduled dose, skip the missed dose and continue with your normal schedule. Never take a double dose to compensate for a missed one. Many people use Tomonil only when symptoms occur rather than on a fixed schedule; in that case simply take the tablet when you actually need it, within the limits of the package leaflet.
It is generally safest to limit or avoid alcohol while taking Tomonil. Alcohol can worsen common side effects of medicines, including drowsiness, dizziness, and stomach upset, and can also alter how the medicine is metabolised by the liver. If you drink alcohol regularly or have a history of liver disease, discuss this with your pharmacist before starting Tomonil so that you can make an informed personal decision.
Over-the-counter status means that Tomonil has demonstrated an acceptable safety profile in the general adult population when used according to the package leaflet. It does not mean the medicine is risk-free. All medicines have possible side effects and drug interactions, and OTC medicines are sometimes combined with other products in ways that create avoidable risks. Use Tomonil only as directed, tell your pharmacist about your other medicines and conditions, and seek professional advice if anything unexpected happens during treatment.
If you are pregnant, think you may be pregnant, or are breastfeeding, do not take Tomonil without first consulting a doctor, midwife, or pharmacist. As a general rule, medicines should only be used during pregnancy or breastfeeding when clearly necessary. Your healthcare provider will weigh the expected benefit of symptom relief against potential risks and may suggest non-pharmacological measures or a better-characterised alternative.
Store Tomonil at room temperature below 25°C (77°F) in the original packaging to protect it from moisture and light. Keep the tablets out of reach and sight of children. Do not use Tomonil after the expiry date printed on the carton or blister – the expiry date refers to the last day of that month. Do not dispose of unused tablets via household waste or the toilet; instead, return them to your pharmacy for safe disposal.
References and Sources
This article is based on internationally recognised medical, pharmaceutical, and regulatory guidelines. All information has been reviewed by qualified healthcare professionals according to evidence-based principles. Consumers should always consult the current package leaflet of the product they are using, as it reflects the most up-to-date approved information for their country.
- European Medicines Agency (EMA). Guideline on Summary of Product Characteristics (SmPC). EMA, 2024. Available at: www.ema.europa.eu
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List, 2023. Geneva: World Health Organization, 2023.
- World Health Organization (WHO). Guidelines for the Regulatory Assessment of Medicinal Products for Use in Self-Medication. WHO, 2000 (reviewed 2023).
- British National Formulary (BNF). Prescribing Guidance: Drug Interactions and Side Effects. NICE, 2024. Available at: bnf.nice.org.uk
- U.S. Food and Drug Administration (FDA). Understanding Over-the-Counter Medicines – Consumer Information. FDA, 2024. Available at: www.fda.gov
- European Pharmacopoeia Commission. European Pharmacopoeia, 11th Edition. Council of Europe, 2023.
- International Council for Harmonisation (ICH). ICH E2C(R2): Periodic Benefit-Risk Evaluation Report. ICH, 2023.
- Goodman & Gilman’s. The Pharmacological Basis of Therapeutics. 14th Edition. McGraw-Hill Education, 2023.
About the Medical Editorial Team
This article has been written and reviewed by iMedic’s Medical Editorial Team, consisting of licensed physicians and specialists in clinical pharmacology with expertise in drug safety, pharmacovigilance, and evidence-based medicine.
iMedic Medical Editorial Team – specialists in clinical pharmacology and drug information. All content is researched and written using peer-reviewed sources and international pharmaceutical guidelines (EMA, FDA, WHO, BNF).
iMedic Medical Review Board – independent panel of qualified physicians who review all drug information content for accuracy, completeness, and clinical relevance according to EMA, FDA, and WHO standards.
Editorial Standards: All pharmaceutical content on iMedic follows strict editorial standards based on the GRADE evidence framework. We do not accept any form of pharmaceutical industry sponsorship or advertising. Our content is independent, evidence-based, and written for patients and caregivers. Read more about our editorial standards.